148 related articles for article (PubMed ID: 15510838)
1. [Interstitial pneumonia during treatment with thalidomide in a patient with multiple myeloma].
Iguchi T; Sakoda M; Chen CK; Yokoyama K; Hattori Y; Ikeda Y; Okamoto S
Rinsho Ketsueki; 2004 Sep; 45(9):1064-6. PubMed ID: 15510838
[TBL] [Abstract][Full Text] [Related]
2. [Interstitial pneumonitis as an adverse effect of thalidomide].
Scholte JB; Potjewijd J; Voogt PJ; Custers FL; Lie KS
Ned Tijdschr Geneeskd; 2009; 153():A452. PubMed ID: 19785872
[TBL] [Abstract][Full Text] [Related]
3. [Interstitial pneumonitis as an adverse effect of thalidomide].
Scholte JB; Potjewijd J; Voogt PJ; Custers FL; Jie KS
Ned Tijdschr Geneeskd; 2009; 153():A452. PubMed ID: 20051154
[TBL] [Abstract][Full Text] [Related]
4. [Case of thalidomide-induced interstitial pneumonia].
Matsushima H; Oda T; Yamamoto M; Sato A; Hasejima N; Takezawa S
Nihon Kokyuki Gakkai Zasshi; 2009 May; 47(5):438-42. PubMed ID: 19514509
[TBL] [Abstract][Full Text] [Related]
5. Lenalidomide-induced interstitial lung disease.
Chen Y; Kiatsimkul P; Nugent K; Raj R
Pharmacotherapy; 2010 Mar; 30(3):325. PubMed ID: 20180616
[TBL] [Abstract][Full Text] [Related]
6. [Two cases of pneumonia caused by Sho-saiko-to].
Tojima H; Yamazaki T; Tokudome T
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Aug; 34(8):904-10. PubMed ID: 8965402
[TBL] [Abstract][Full Text] [Related]
7. Side effects and good effects from new chemotherapeutic agents. Case 2. Thalidomide-induced interstitial pneumonitis.
Onozawa M; Hashino S; Sogabe S; Haneda M; Horimoto H; Izumiyama K; Kondo T; Aldana LP; Hamada K; Asaka M
J Clin Oncol; 2005 Apr; 23(10):2425-6. PubMed ID: 15800335
[No Abstract] [Full Text] [Related]
8. Leukocytoclastic vasculitis due to thalidomide in multiple myeloma.
Yildirim ND; Ayer M; Küçükkaya RD; Alpay N; Mete O; Yenerel MN; Yavuz AS; Nalçaci M
Jpn J Clin Oncol; 2007 Sep; 37(9):704-7. PubMed ID: 17709605
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide induced nonspecific interstitial pneumonia in patient with relapsed multiple myeloma.
Kang MH; Ju JH; Kim HG; Kang JH; Jeon KN; Kim HC; Lee GW
Korean J Intern Med; 2010 Dec; 25(4):447-9. PubMed ID: 21179284
[TBL] [Abstract][Full Text] [Related]
10. [Fulminant interstitial pneumonia associated with polyarteritis nodosa].
Ida M; Iwata M; Horiguchi T; Oda S; Takeuchi E; Nakamura Y; Satou A
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Nov; 34(11):1283-8. PubMed ID: 8976088
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide-associated thrombocytopenia.
Duyvendak M; Naunton M; Kingma BJ; Brouwers JR
Ann Pharmacother; 2005 Nov; 39(11):1936-9. PubMed ID: 16219892
[TBL] [Abstract][Full Text] [Related]
12. [A case of acute interstitial pneumonia caused by blasticidin S].
Toyoshima M; Sato A; Taniguchi M; Imokawa S; Nakazawa K; Hayakawa H; Chida K
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Apr; 32(4):344-7. PubMed ID: 8041044
[TBL] [Abstract][Full Text] [Related]
13. [Brief report: stroke in multiple myeloma patient treated with thalidomide].
Ito Y; Mori A; Yonemura K; Hashimoto Y; Hirano T; Uchino M
Rinsho Shinkeigaku; 2007 Sep; 47(9):593-6. PubMed ID: 18018619
[TBL] [Abstract][Full Text] [Related]
14. Should we screen patients for inherited thrombophilia before starting thalidomide?
Otrock ZK; Mahfouz RA; El-Hajj II; Harb MI; Sawaya RA
Am J Clin Oncol; 2006 Feb; 29(1):100-1. PubMed ID: 16462512
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival.
Schütt P; Ebeling P; Buttkereit U; Brandhorst D; Opalka B; Poser M; Müller S; Flasshove M; Moritz T; Seeber S; Nowrousian MR
Ann Hematol; 2005 Sep; 84(9):594-600. PubMed ID: 15744524
[TBL] [Abstract][Full Text] [Related]
16. Reversible pulmonary toxicity due to lenalidomide.
Coates S; Barker A; Spurgeon S
J Oncol Pharm Pract; 2012 Jun; 18(2):284-6. PubMed ID: 21742815
[TBL] [Abstract][Full Text] [Related]
17. Development of neuropathy in patients with myeloma treated with thalidomide: patterns of occurrence and the role of electrophysiologic monitoring.
Mileshkin L; Stark R; Day B; Seymour JF; Zeldis JB; Prince HM
J Clin Oncol; 2006 Sep; 24(27):4507-14. PubMed ID: 16940275
[TBL] [Abstract][Full Text] [Related]
18. Two cases of bacterial meningitis accompanied by thalidomide therapy in patients with multiple myeloma: is thalidomide associated with bacterial meningitis?
Pasa S; Altintas A; Cil T; Ustun C; Bayan K; Danis R; Urakci Z; Tuzun Y; Ayyildiz O
Int J Infect Dis; 2009 Jan; 13(1):e19-22. PubMed ID: 18621563
[TBL] [Abstract][Full Text] [Related]
19. A case of suspected S-1 induced interstitial pneumonia.
Shitara K; Munakata M; Koizumi W; Sakata Y
Gan To Kagaku Ryoho; 2007 Apr; 34(4):619-22. PubMed ID: 17431352
[TBL] [Abstract][Full Text] [Related]
20. [Recurrent multiple lung lesions synchronizing with the disease activity of multiple myeloma].
Matsuoka S; Hosono N; Matsuda Y; Oiwa K; Ookura M; Tai K; Anzai M; Nemoto T; Ishizuka T; Nakamoto Y; Yamauchi T
Rinsho Ketsueki; 2017; 58(12):2406-2410. PubMed ID: 29332875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
